phosphatidylcholines has been researched along with sulfasalazine in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (sulfasalazine) | Trials (sulfasalazine) | Recent Studies (post-2010) (sulfasalazine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 4,437 | 585 | 938 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | sulfasalazine (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | 3 | |
| Carbonic anhydrase 1 | Homo sapiens (human) | 3.04 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.49 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 6.332 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 9.6 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.46 | |
| Cystine/glutamate transporter | Homo sapiens (human) | 0.16 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, Y; Horie, K; Hoshino, J; Miyauchi, S; Mizuno, S; Sekiguchi, T; Yamazaki, C | 1 |
| Brandl, M; Flaten, GE; Luthman, K; Skar, M | 1 |
2 other study(ies) available for phosphatidylcholines and sulfasalazine
| Article | Year |
|---|---|
Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sulfate sodium.
Topics: Animals; Colitis, Ulcerative; Dextran Sulfate; Gastrointestinal Agents; Humans; Leukocyte Count; Male; Phosphatidylcholines; Rats; Rats, Wistar; Recombinant Proteins; Sulfasalazine; Superoxide Dismutase | 1997 |
Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Electric Impedance; Fluoresceins; Lipid Bilayers; Membranes, Artificial; Naproxen; Permeability; Pharmaceutical Preparations; Phosphatidylcholines; Phospholipids; Spectrophotometry, Ultraviolet; Sulfasalazine; Thermodynamics | 2007 |